{"entity":{"type":"insider","cik":"0001662395","url":"/insider/0001662395","json_url":"/insider/0001662395.json","name":"Wilson Jason Douglas","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":43,"n_filings":15,"first":"2019-01-09","last":"2019-12-17","span_basis":"filed_date"},"name_variants":[{"name":"Wilson Jason Douglas","source":"filing","n_filings":15,"first_seen":"2019-01-09","last_seen":"2019-12-17"}],"transactions":[{"id":7929346,"accession":"0001209191-19-060929","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-19-060929","line_url":"/filing/0001209191-19-060929","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662395","owner_name":"Wilson Jason Douglas","owner_display_name":"Wilson Jason Douglas","owner_url":"/insider/0001662395","role":"Officer (Executive VP of Operations)","role_mark":"O","role_mark_label":"Officer (Executive VP of Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP of Operations","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":203.2591336,"price_display":"203.26","price_state":"stated","total_value":2032591.336,"total_display":"2,032,591.34","total_whole":"2,032,591","shares_owned_after":17750.0,"shares_owned_after_display":"17,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-16","filed_date":"2019-12-17","scope":"insider","n_lines":8},{"id":7928538,"accession":"0001209191-19-053686","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-053686","line_url":"/filing/0001209191-19-053686#line-2","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662395","owner_name":"Wilson Jason Douglas","owner_display_name":"Wilson Jason Douglas","owner_url":"/insider/0001662395","role":"Officer (Executive VP of Operations)","role_mark":"O","role_mark_label":"Officer (Executive VP of Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP of Operations","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":170.0,"price_display":"170.00","price_state":"stated","total_value":1700000.0,"total_display":"1,700,000.00","total_whole":"1,700,000","shares_owned_after":7350.0,"shares_owned_after_display":"7,350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-17","filed_date":"2019-10-21","scope":"insider"},{"id":8010593,"accession":"0001209191-19-053134","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-19-053134","line_url":"/filing/0001209191-19-053134","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662395","owner_name":"Wilson Jason Douglas","owner_display_name":"Wilson Jason Douglas","owner_url":"/insider/0001662395","role":"Officer (Executive VP of Operations)","role_mark":"O","role_mark_label":"Officer (Executive VP of Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP of Operations","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":146.13042533333333,"price_display":"146.13","price_state":"stated","total_value":2191956.38,"total_display":"2,191,956.38","total_whole":"2,191,956","shares_owned_after":10550.0,"shares_owned_after_display":"10,550","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-15","filed_date":"2019-10-15","scope":"insider","n_lines":3},{"id":8010580,"accession":"0001209191-19-053134","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-053134","line_url":"/filing/0001209191-19-053134#line-2","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662395","owner_name":"Wilson Jason Douglas","owner_display_name":"Wilson Jason Douglas","owner_url":"/insider/0001662395","role":"Officer (Executive VP of Operations)","role_mark":"O","role_mark_label":"Officer (Executive VP of Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP of Operations","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":100.0,"price_display":"100.00","price_state":"stated","total_value":1500000.0,"total_display":"1,500,000.00","total_whole":"1,500,000","shares_owned_after":7350.0,"shares_owned_after_display":"7,350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-14","filed_date":"2019-10-15","scope":"insider"},{"id":8068154,"accession":"0001209191-19-046280","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-046280","line_url":"/filing/0001209191-19-046280","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662395","owner_name":"Wilson Jason Douglas","owner_display_name":"Wilson Jason Douglas","owner_url":"/insider/0001662395","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":72.6836755,"price_display":"72.68","price_state":"stated","total_value":290734.702,"total_display":"290,734.70","total_whole":"290,735","shares_owned_after":1872.0,"shares_owned_after_display":"1,872","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-15","filed_date":"2019-08-16","scope":"insider","n_lines":3},{"id":8599467,"accession":"0001209191-19-042341","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-042341","line_url":"/filing/0001209191-19-042341","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662395","owner_name":"Wilson Jason Douglas","owner_display_name":"Wilson Jason Douglas","owner_url":"/insider/0001662395","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":84.638991425,"price_display":"84.64","price_state":"stated","total_value":338555.9657,"total_display":"338,555.97","total_whole":"338,556","shares_owned_after":2189.0,"shares_owned_after_display":"2,189","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-15","filed_date":"2019-07-17","scope":"insider","n_lines":3},{"id":7927293,"accession":"0001209191-19-037987","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-19-037987","line_url":"/filing/0001209191-19-037987","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662395","owner_name":"Wilson Jason Douglas","owner_display_name":"Wilson Jason Douglas","owner_url":"/insider/0001662395","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":83.544137575,"price_display":"83.54","price_state":"stated","total_value":334176.5503,"total_display":"334,176.55","total_whole":"334,177","shares_owned_after":495.0,"shares_owned_after_display":"495","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-17","filed_date":"2019-06-19","scope":"insider","n_lines":4},{"id":8598619,"accession":"0001209191-19-030723","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-030723","line_url":"/filing/0001209191-19-030723","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662395","owner_name":"Wilson Jason Douglas","owner_display_name":"Wilson Jason Douglas","owner_url":"/insider/0001662395","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":89.907785,"price_display":"89.91","price_state":"stated","total_value":359631.14,"total_display":"359,631.14","total_whole":"359,631","shares_owned_after":1500.0,"shares_owned_after_display":"1,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-15","filed_date":"2019-05-17","scope":"insider","n_lines":3},{"id":8725040,"accession":"0001209191-19-024731","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-19-024731","line_url":"/filing/0001209191-19-024731","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662395","owner_name":"Wilson Jason Douglas","owner_display_name":"Wilson Jason Douglas","owner_url":"/insider/0001662395","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":83.8154102,"price_display":"83.82","price_state":"stated","total_value":335261.6408,"total_display":"335,261.64","total_whole":"335,262","shares_owned_after":1593.0,"shares_owned_after_display":"1,593","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-15","filed_date":"2019-04-16","scope":"insider","n_lines":4},{"id":7922004,"accession":"0001209191-19-020743","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-19-020743","line_url":"/filing/0001209191-19-020743","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662395","owner_name":"Wilson Jason Douglas","owner_display_name":"Wilson Jason Douglas","owner_url":"/insider/0001662395","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28396.0,"shares_display":"28,396","price_per_share":93.50643027891252,"price_display":"93.51","price_state":"stated","total_value":2655208.5942,"total_display":"2,655,208.59","total_whole":"2,655,209","shares_owned_after":8449.0,"shares_owned_after_display":"8,449","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-19","filed_date":"2019-03-21","scope":"insider","n_lines":4},{"id":8313026,"accession":"0001209191-19-020406","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-020406","line_url":"/filing/0001209191-19-020406#line-4","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662395","owner_name":"Wilson Jason Douglas","owner_display_name":"Wilson Jason Douglas","owner_url":"/insider/0001662395","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1604.0,"shares_display":"1,604","price_per_share":95.11,"price_display":"95.11","price_state":"stated","total_value":152556.44,"total_display":"152,556.44","total_whole":"152,556","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-18","filed_date":"2019-03-19","scope":"insider"},{"id":8313017,"accession":"0001209191-19-020406","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-020406","line_url":"/filing/0001209191-19-020406#line-2","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662395","owner_name":"Wilson Jason Douglas","owner_display_name":"Wilson Jason Douglas","owner_url":"/insider/0001662395","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":93.6174,"price_display":"93.62","price_state":"stated","total_value":374469.6,"total_display":"374,469.60","total_whole":"374,470","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-15","filed_date":"2019-03-19","scope":"insider"},{"id":8151784,"accession":"0001209191-19-010954","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-010954","line_url":"/filing/0001209191-19-010954#line-2","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662395","owner_name":"Wilson Jason Douglas","owner_display_name":"Wilson Jason Douglas","owner_url":"/insider/0001662395","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":85.44,"price_display":"85.44","price_state":"stated","total_value":341760.0,"total_display":"341,760.00","total_whole":"341,760","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-15","filed_date":"2019-02-19","scope":"insider"},{"id":7945163,"accession":"0001209191-19-007666","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-007666","line_url":"/filing/0001209191-19-007666#line-2","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662395","owner_name":"Wilson Jason Douglas","owner_display_name":"Wilson Jason Douglas","owner_url":"/insider/0001662395","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":80.0,"price_display":"80.00","price_state":"stated","total_value":240000.0,"total_display":"240,000.00","total_whole":"240,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-05","filed_date":"2019-02-06","scope":"insider"},{"id":7797308,"accession":"0001209191-19-006736","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-006736","line_url":"/filing/0001209191-19-006736#line-4","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662395","owner_name":"Wilson Jason Douglas","owner_display_name":"Wilson Jason Douglas","owner_url":"/insider/0001662395","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":865.0,"shares_display":"865","price_per_share":80.0,"price_display":"80.00","price_state":"stated","total_value":69200.0,"total_display":"69,200.00","total_whole":"69,200","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-01","filed_date":"2019-02-04","scope":"insider"},{"id":7797304,"accession":"0001209191-19-006736","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-006736","line_url":"/filing/0001209191-19-006736#line-2","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662395","owner_name":"Wilson Jason Douglas","owner_display_name":"Wilson Jason Douglas","owner_url":"/insider/0001662395","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6135.0,"shares_display":"6,135","price_per_share":80.0,"price_display":"80.00","price_state":"stated","total_value":490800.0,"total_display":"490,800.00","total_whole":"490,800","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-31","filed_date":"2019-02-04","scope":"insider"},{"id":8342020,"accession":"0001209191-19-003934","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-003934","line_url":"/filing/0001209191-19-003934","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662395","owner_name":"Wilson Jason Douglas","owner_display_name":"Wilson Jason Douglas","owner_url":"/insider/0001662395","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":71.1472268,"price_display":"71.15","price_state":"stated","total_value":284588.9072,"total_display":"284,588.91","total_whole":"284,589","shares_owned_after":1272.0,"shares_owned_after_display":"1,272","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-15","filed_date":"2019-01-16","scope":"insider","n_lines":2},{"id":8003228,"accession":"0001209191-19-003067","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-003067","line_url":"/filing/0001209191-19-003067#line-2","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662395","owner_name":"Wilson Jason Douglas","owner_display_name":"Wilson Jason Douglas","owner_url":"/insider/0001662395","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":72.041,"price_display":"72.04","price_state":"stated","total_value":1440820.0,"total_display":"1,440,820.00","total_whole":"1,440,820","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-07","filed_date":"2019-01-09","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":43,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":43,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":43},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001358762","name":"REATA PHARMACEUTICALS INC","url":"/issuer/0001358762","role":"Officer (Executive VP of Operations)","n_filings":15,"first_seen":"2019-01-09","last_seen":"2019-12-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001662395","retrieved_at":"2026-08-25T07:44:00+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}